Victory Capital Management Inc Intercept Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$39.09 - $53.44 $945,157 - $1.29 Million	-24,179 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$46.7 - $92.04 $967,063 - $1.91 Million	20,708 Added 596.6%	24,179 $1.16 Million
Q1 2020 May 04, 2020	SELL	$48.35 - $118.68 $20,500 - $50,320	-424 Reduced 10.89%	3,471 $219,000
Q4 2019 Feb 06, 2020	BUY	$57.36 - $124.1 $20,477 - $44,303	357 Added 10.09%	3,895 $483,000
Q4 2019 Feb 04, 2020	SELL	$57.36 - $124.1 $6,481 - $14,023	-113 Reduced 3.1%	3,538 $327,000
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $214,277 - $293,759	3,651 New	3,651 $242,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.